Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Hepato-Gastroenterology

• Publication date

  2006-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 17153445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intercellular adhesion molecule-1

  2020cited by this paper
• Local Release of Human Neutrophil Lipocalin (HNL), IL-8, and TNF-α Is Decreased as Response to Topical Prednisolone Treatment in Distal Ulcerative Colitis and Proctitis

  2002cited by this paper
• Soluble adhesion molecules in inflammatory bowel disease

  2001cited by this paper
• Changed colonic profile of P‐selectin, platelet‐endothelial cell adhesion molecule‐1 (PECAM‐1), intercellular adhesion molecule‐1 (ICAM‐1), ICAM‐2, and ICAM‐3 in inflammatory bowel disease

  2000cited by this paper
• Established and emerging biological activity markers of inflammatory bowel disease.

  2000cited by this paper
• Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis

  1998cited by this paper
• Mucosal Expression of Interleukin-6 and Interleukin-8 Messenger RNA in Ulcerative Colitis and in Crohn's Disease

  1998cited by this paper
• Increased mucosal concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), sE-selectin, and interleukin-8 in active ulcerative colitis

  1996cited by this paper
• Transcriptional regulation of endothelial cell adhesion molecules: NF‐κB and cytokine‐inducible enhancers

  1995cited by this paper
• Adhesion molecules in inflammatory bowel disease.

  1995cited by this paper
• Circulating soluble adhesion molecules in inflammatory bowel disease

  1995cited by this paper
• Role of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in rat experimental colitis.

  1994cited by this paper
• Enhanced intestinal synthesis of interleukin-6 is related to the disease severity and activity in ulcerative colitis.

  1994cited by this paper
• Elevation of circulating interleukin 6 after surgery: factors influencing the serum level.

  1994cited by this paper
• Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.

  1994cited by this paper
• Serum tumor necrosis factor activity in inflammatory bowel disease.

  1992cited by this paper
• Expression of vascular adhesion molecules in inflammatory bowel disease.

  1992cited by this paper
• Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis.

  1992cited by this paper
• Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease.

  1992cited by this paper
• Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

  1991cited by this paper
• High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.

  1991cited by this paper
• Adhesion receptors of the immune system

  1990cited by this paper
• Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

  1989cited by this paper
• The biology of interleukin-6.

  1989cited by this paper
• Incidence rates of ulcerative colitis and Crohn's disease in fifteen areas of the United States.

  1981cited by this paper
• In vitro studies of inflammatory bowel disease. Surface receptors of the mononuclear cell required to lyse allogeneic colonic epithelial cells.

  1976cited by this paper

• Identification of Key Biomarkers and Immune Microenvironment Features in Ulcerative Colitis: An Integrated Analysis Using WGCNA and Multiple Machine Learning Algorithms

  2025cites this paper
• The importance of growth differentiation factor 15 and interleukin 6 serum levels in inflammatory bowel diseases

  2024cites this paper
• Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?

  2024cites this paper
• Long Non-Coding RNA ANRIL Regulates Inflammatory Factor Expression in Ulcerative Colitis Via the miR-191-5p/SATB1 Axis

  2023cites this paper
• ICAM-1 and VCAM-1: gatekeepers in various inflammatory and cardiovascular disorders.

  2023cites this paper
• Establishment of a lipopolysaccharide-induced inflammation model of human fetal colon cells

  2023cites this paper
• miR‑146a‑5p negatively regulates the IL‑1β‑stimulated inflammatory response via downregulation of the IRAK1/TRAF6 signaling pathway in human intestinal epithelial cells

  2022cites this paper
• Pilot study of cytokine changes evaluation after fecal microbiota transplantation in patients with ulcerative colitis.

  2020cites this paper
• ANEMIA IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS

  2020cites this paper
• Elucidation of colon-protective efficacy of diosgenin in experimental TNBS-induced colitis: inhibition of NF-κB/IkB-α and Bax/Caspase-1 signaling pathways

  2020cites this paper
• Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease—Focusing on Intestinal Barrier Function

  2019cites this paper
• Epimagnolin A inhibits IL‐6 production by inhibiting p38/NF‐κB and AP‐1 signaling pathways in PMA‐stimulated THP‐1 cells

  2019cites this paper
• Olive oil polyphenols reduce oxysterols -induced redox imbalance and pro-inflammatory response in intestinal cells

  2018cites this paper
• Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis

  2018cites this paper
• Effect of hesperetin on inflammatory and oxidative status in trinitrobenzene sulfonic acid-induced experimental colitis model.

  2018cites this paper
• Estudi transcripcional de la Colitis Ulcerosa. Caracterització i cerca de biomarcadors

  2018cites this paper
• Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice.

  2017cites this paper
• The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease

  2017cites this paper
• Comorbidity of Allergic and Autoimmune Diseases Among Patients With ADHD

  2017cites this paper
• Sleeve Gastrectomy in Canine: Effect on Weight Loss, Inflammation andOxidative Stress Markers while Leaving Blind Intestinal Loop in Place

  2017cites this paper
• Antioxidant and anti-inflammatory activity of aqueous fraction from Albizia lebbeck leaves

  2017cites this paper
• Astragalus polysaccharides protect against dextran sulfate sodium-induced colitis by inhibiting NF-κВ activation.

  2017cites this paper
• Efficacy of single vs multiple doses of 5-aminosalicylic acid ( 5-ASA ) in the treatment of mild-moderate ulcerative colitis : an open randomized clinical trial

  2016cites this paper
• AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial.

  2016cites this paper
• Plasma‐induced signatures reveal an extracellular milieu possessing an immunoregulatory bias in treatment‐naive paediatric inflammatory bowel disease

  2016cites this paper
• Assessment of Disease‐Related Therapeutic Protein Drug‐Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis

  2016cites this paper
• First case report of exacerbated ulcerative colitis after anti-interleukin-6R salvage therapy.

  2015cites this paper
• Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn’s Colitides

  2015cites this paper
• Usefulness of selected laboratory markers in ulcerative colitis

  2015cites this paper
• From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis

  2015cites this paper
• Effect of Ethanol Consumption on Colon of Normal Rats as Well as Rats with Experimentally-Induced Ulcerative Colitis

  2015cites this paper
• Serotonin regulates innate immune responses of colon epithelial cells through Nox2-derived reactive oxygen species.

  2014cites this paper
• Dramatic Changes of Matrix Metalloproteinases-7 and Lysozyme in the Ulcerative Colitis of Mice Induced by Dextran Sulfate Sodium

  2014cites this paper
• Protective effects of Pogostemon cablin Bentham water extract on inflammatory cytokine expression in TNBS-induced colitis in rats

  2014cites this paper
• Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients.

  2014cites this paper
• b-Arrestin-1 De fi ciency Protects Mice from Experimental Colitis

  2013influential citation
• Review: new anti-cytokines for IBD: what is in the pipeline?

  2013cites this paper
• Sleep, immunity and inflammation in gastrointestinal disorders.

  2013cites this paper
• Anti-IL-6 treatment for inflammatory bowel diseases: next cytokine, next target.

  2013cites this paper
• Preoperative exercise capacity in adult inflammatory bowel disease sufferers, determined by cardiopulmonary exercise testing

  2012cites this paper
• Interleukin-6 Induces S100A9 Expression in Colonic Epithelial Cells through STAT3 Activation in Experimental Ulcerative Colitis

  2012cites this paper
• STW 5 is effective in dextran sulfate sodium-induced colitis in rats

  2012influential citation
• Amelioration of Dextran Sodium Sulfate-Induced Colitis in Mice by Rhodobacter sphaeroides Extract

  2012cites this paper
• The Effect of Small Organic Compounds on Triple Negative Breast Cancer Cells

  2012cites this paper
• Effect of moxibustion on the expressions of protein KGF-1, KGF-2 and IL-6 in colon of rats with ulcerative colitis

  2012influential citation
• β-Arrestin-1 deficiency protects mice from experimental colitis.

  2012cites this paper
• Role of serum cytokine profile in ulcerative colitis assessment

  2012cites this paper
• 1,3-Diphenylpropenone ameliorates TNBS-induced rat colitis through suppression of NF-κB activation and IL-8 induction.

  2012cites this paper
• IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.

  2011cites this paper
• Polyphenol supplementation as a complementary medicinal approach to treating inflammatory bowel disease.

  2011cites this paper
• Clinical utility of biochemical markers in ulcerative colitis among Egyptian patients

  2010influential citation
• l-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis.

  2010cites this paper
• Can systemic cytokines predict relapse of inflammatory bowel disease?

  2010cites this paper
• Melatonin and ulcerative colitis: Evidence, biological mechanisms, and future research

  2009cites this paper
• Genetic polymorphisms of interleukin 8 and risk of ulcerative colitis in the Chinese population.

  2009cites this paper
• Therapeutic potential of hen egg white peptides for the treatment of intestinal inflammation

  2009cites this paper
• The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer.

  2008cites this paper
• Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells.

  2008cites this paper
• An experimental study on ulcerative colitis as a potential target for probiotic therapy by Lactobacillus acidophilus with or without "olsalazine".

  2008cites this paper
• Inflammatory bowel disease in the pediatric patient.

  2007cites this paper
• Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease

  2007cites this paper
• Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance.

  2007cites this paper
• Increased gastric cytokine production after Roux-en-Y gastric bypass for morbid obesity.

  2007cites this paper